Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7Recruiting
NCT04613596Phase 2, Phase 3Updated Aug 5, 2026
Sponsor: Mirati Therapeutics Inc.
Advanced Non-Small Cell Lung Cancer · Metastatic Non-Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +42 more
IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal SurgeryRecruiting
NCT07346066Phase 3Updated Aug 5, 2026
Sponsor: Intuitive Surgical
Ureter Injury
United States
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic LeukemiaRecruiting
NCT03150693Phase 3Updated Aug 5, 2026
Sponsor: Alliance for Clinical Trials in Oncology
B Acute Lymphoblastic Leukemia
United States, Canada
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus PembrolizumabRecruiting
NCT05812807Phase 3Updated Aug 5, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Anatomic Stage II Breast Cancer AJCC v8 · Early Stage Triple-Negative Breast Carcinoma · Anatomic Stage IIIA Breast Cancer AJCC v8 · Anatomic Stage IIIB Breast Cancer AJCC v8
United States, Canada, Puerto Rico
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASHRecruiting
NCT06419374Phase 3Updated Aug 5, 2026
Sponsor: 89bio, Inc.
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
United States, Argentina, Australia, Belgium, Brazil +20 more
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia BRecruiting
NCT07080905Phase 3Updated Aug 5, 2026
Sponsor: CSL Behring
Hemophilia B
United States, Austria, Belgium, France, Israel +2 more
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialRecruiting
NCT07200830Phase 3Updated Aug 5, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Metastatic Castration-Resistant Prostate Carcinoma · Metastatic Prostate Adenocarcinoma · Stage IVB Prostate Cancer AJCC v8
United States
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the Treatment of Adult Upper Limb Spasticity .Recruiting
NCT07242300Phase 3Updated Aug 5, 2026
Sponsor: JHM BioPharma (Tonghua) Co. , Ltd.
Upper Limb Spasticity (ULS)
China
A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working EfficientlyRecruiting
NCT07154745Phase 3Updated Aug 5, 2026
Sponsor: Regeneron Pharmaceuticals
Paroxysmal Nocturnal Hemoglobinuria
Brazil, Canada, Italy, Poland, South Korea +2 more
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)Recruiting
NCT06822426Phase 3Updated Aug 5, 2026
Sponsor: CorMedix Therapeutics
Central Line Associated Blood Stream Infections (CLABSI)
United States, Turkey (Türkiye)
A Study of Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of RecurrenceRecruiting
NCT07475026Phase 3Updated Aug 5, 2026
Sponsor: Tianjin Medical University Cancer Institute and Hospital
HCC - Hepatocellular Carcinoma
China
Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung TransplantRecruiting
NCT05654922Phase 3Updated Aug 5, 2026
Sponsor: Renovion, Inc.
Pre-Bronchiolitis Obliterans Syndrome
United States
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking RuxolitinibRecruiting
NCT07623161Phase 3Updated Aug 5, 2026
Sponsor: Takeda
Myelofibrosis · Anemia
United States, Argentina, Australia, Austria, Belgium +26 more
Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar LinesRecruiting
NCT06937944Phase 3Updated Aug 5, 2026
Sponsor: JHM BioPharma (Tonghua) Co. , Ltd.
Moderate to Severe Glabellar Lines
China
Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic MalignancyRecruiting
NCT06895538Phase 2, Phase 3Updated Aug 5, 2026
Sponsor: Peking University First Hospital
Leukemia · MDS · Lymphoma
China
Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian CancerRecruiting
NCT07564141Phase 3Updated Aug 5, 2026
Sponsor: Genmab
Platinum-Sensitive Ovarian Cancer · Ovarian Cancer
United States
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric AdenocarcinomaRecruiting
NCT05677490Phase 3Updated Aug 5, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Advanced Esophageal Adenocarcinoma · Advanced Gastric Adenocarcinoma · Advanced Gastroesophageal Junction Adenocarcinoma · Clinical Stage III Esophageal Adenocarcinoma AJCC v8
United States, Puerto Rico
NO During CPB in Neonates to Reduce Risk of AKIRecruiting
NCT04216927Phase 3Updated Aug 5, 2026
Sponsor: Children's Hospital Medical Center, Cincinnati
AKI · CHD - Congenital Heart Disease · Surgery
United States
Phase III Study to Evaluate the Safety, Efficacy, and Impact on Quality of Life of Capivasertib Alongside Standard-of-care Endocrine Treatment in Patients With HR+/HER2- Advanced Breast Cancer and Progression on Prior Endocrine-based TreatmentRecruiting
NCT07281833Phase 3Updated Aug 5, 2026
Sponsor: Women's Cancer Study Group GmbH
Breast Cancer · HR-positive Breast Cancer · Advanced Breast Cancer · Metastatic Breast Cancer
Belgium, Germany, Portugal
Dexmedetomidine in Reducing Postoperative Delirium in Cardiac Surgery PatientsRecruiting
NCT06619912Phase 3Updated Aug 5, 2026
Sponsor: Xijing Hospital
Postoperative Delirium · Preoperative Sleep Disorder
China
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)Recruiting
NCT06952504Phase 3Updated Aug 5, 2026
Sponsor: Merck Sharp & Dohme LLC
Endometrial Cancer
United States, Argentina, Australia, Austria, Belgium +29 more
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative ColitisRecruiting
NCT06588855Phase 3Updated Aug 5, 2026
Sponsor: Hoffmann-La Roche
Moderately to Severely Active Ulcerative Colitis
United States, Argentina, Australia, Austria, Belgium +25 more
Reaching Rural Cancer Survivors Who Smoke Using Text-Based ProgramRecruiting
NCT05008848Phase 3Updated Aug 5, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Cigarette Smoking-Related Carcinoma
United States
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus TrastuzumabRecruiting
NCT06876714Phase 3Updated Aug 5, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Early Stage HER2+ Breast Cancer
United States, Puerto Rico
Choline and Iron DeficiencyRecruiting
NCT06527391Phase 2, Phase 3Updated Aug 5, 2026
Sponsor: University of Minnesota
Pediatric Iron Deficiency · Anemia
United States

Previous page Next page